drugset / Trial / NCT00554762

Dose Response and Efficacy of GW842166 in Pain

NCT00554762 ↗

Phase 1 Withdrawn GlaxoSmithKline
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to assess the dose response and efficacy of single and repeat doses of GW842166 in healthy volunteers using pharmacodynamic pain assessments.

Timeline

Start
2007-11
Primary completion
2008-03
Completion
2008-03

Outcome

Outcome not reported

Stopped: “Compound terminated”

Drugs

EvaluationDrugModalityDoseRoute
Subject GW842166X Small molecule — —

Indications

No indication recorded.